Stock Earnings

Question 1

What are Cognition Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Cognition Therapeutics Inc has a total asset of $30, Net loss of $-33

Question 2

What are the key financial ratios for CGTX?

Accepted Answer

Cognition Therapeutics Inc's Current ratio is 2.72, has a Net margin is 0, sales per share of $0.

Question 3

How is Cognition Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Cognition Therapeutics Inc data is not available.

Question 4

Is Cognition Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Cognition Therapeutics Inc has a net loss of $-33

Question 5

Does Cognition Therapeutics Inc have any liabilities?

Accepted Answer

yes, Cognition Therapeutics Inc has liability of 11

Question 6

How many outstanding shares for Cognition Therapeutics Inc?

Accepted Answer

Cognition Therapeutics Inc has a total outstanding shares of 59.85

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	10	12	13	13	10	4
Research & Development	34	41	37	30	18	12
Operating Expenses	44	53	50	43	28	17
Other Non Operating Income (Expenses)	16	20	24	22	15	11
Pretax Income	-27	-33	-25	-21	-11	-7
Income Tax Expense	--	0	--	--	--	--
Net Income	-27	-33	-25	-21	-16	-12
Net Income Growth	-21%	32%	19%	31%	33%	50%
Shares Outstanding (Diluted)	77.95	39.73	30.02	23.64	22.58	20.95
Shares Change (YoY)	93%	32%	27%	5%	8%	0%
EPS (Diluted)	-0.35	-0.85	-0.85	-0.91	-0.72	-0.58
EPS Growth	-57.99%	0%	-6%	26%	24%	38%
Free Cash Flow	-29	-28	-16	-18	-3	-3
Free Cash Flow Per Share	-0.37	-0.7	-0.53	-0.76	-0.13	-0.14
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-44	-53	-50	-43	-28	-17
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-44	-53	-50	-43	-28	-17
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Cognition Therapeutics Inc (CGTX) Price